Cargando…
No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis
OBJECTIVE: The use of anti-tumor necrosis factor (TNF) agents to treat joint manifestations of sarcoidosis has not been described. We evaluated the efficacy and safety of three such biologics in patients with these symptoms refractory to conventional therapy (nonsteroidal anti-inflammatory drugs, co...
Autores principales: | Banse, Christopher, Bisson-Vaivre, Aurélia, Kozyreff-Meurice, Marie, Vittecoq, Olivier, Goëb, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724565/ https://www.ncbi.nlm.nih.gov/pubmed/23901289 http://dx.doi.org/10.2147/IJGM.S44542 |
Ejemplares similares
-
Outcome of patients with sarcoidosis refractory to TNF antagonists: a case series
por: Thery-Casari, Clémence, et al.
Publicado: (2018) -
Hepatic sarcoidosis: a case series
por: Ennaifer, Rym, et al.
Publicado: (2016) -
Sarcoidosis and colon cancer: a possible association
por: Stanziola, Anna Agnese, et al.
Publicado: (2018) -
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008) -
Subcutaneous sarcoidosis: A case series of 19 patients
por: Lopez-Sundh, AE, et al.
Publicado: (2021)